BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21511816)

  • 21. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients.
    van Ree RM; Oterdoom LH; de Vries AP; Gansevoort RT; van der Heide JJ; van Son WJ; Ploeg RJ; de Jong PE; Gans RO; Bakker SJ
    Nephrol Dial Transplant; 2007 Jan; 22(1):246-53. PubMed ID: 16998222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplant Proc; 2006 Dec; 38(10):3434-6. PubMed ID: 17175295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of "high-producer" interleukin-6 haplotypes on cardiovascular morbidity and mortality in a kidney transplant population.
    Krüger B; Walberer A; Farkas S; Tokmak F; Obed A; Schenker P; Henning B; Schlitt HJ; Krämer BK; Banas B
    Transplant Proc; 2009; 41(6):2539-43. PubMed ID: 19715970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum C-reactive protein surge in renal transplant recipients: link with allograft survival.
    Ozdemir NF; Elsurer R; Ibis A; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):934-7. PubMed ID: 17524855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
    Karbowska A; Boratynska M; Kusztal M; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
    Fellström B; Holdaas H; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Staffler B; Pedersen TR;
    Transplantation; 2005 Jan; 79(2):205-12. PubMed ID: 15665769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of renal transplantation in recipients with Wegener's granulomatosis.
    Shen J; Gill J; Shangguan M; Sampaio MS; Bunnapradist S
    Clin Transplant; 2011; 25(3):380-7. PubMed ID: 20394635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum phosphate and calcium concentrations are associated with reduced patient survival following kidney transplantation.
    Moore J; Tomson CR; Tessa Savage M; Borrows R; Ferro CJ
    Clin Transplant; 2011; 25(3):406-16. PubMed ID: 20608946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal transplant in patients with spinal cord injuries.
    Basiri A; Shakhssalim N; Hosseini-Moghddam SM; Parvaneh MJ; Azadvari M
    Exp Clin Transplant; 2009 Mar; 7(1):28-32. PubMed ID: 19364309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in proteinuria >200 mg/g after late rejection is associated with poor graft survival.
    Djamali A; Samaniego M; Torrealba J; Pirsch J; Muth BL
    Nephrol Dial Transplant; 2010 Apr; 25(4):1300-6. PubMed ID: 19934095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol.
    Ibrahim H; Rogers T; Casingal V; Sturdevant M; Tan M; Humar A; Gillingham K; Matas A
    Transplantation; 2006 Jan; 81(2):214-9. PubMed ID: 16436965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why does kidney allograft fail? A long-term single-center experience.
    Alarrayed S; El-Agroudy A; Al-Arrayed A; Ghareeb S; Farid E; Garadah T; Abdulla S
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):818-24. PubMed ID: 21743242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of chronic periodontitis on serum TNF-alpha, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients.
    Blach A; Franek E; Witula A; Kolonko A; Chudek J; Drugacz J; Wiecek A
    Clin Transplant; 2009; 23(2):213-9. PubMed ID: 19191811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients.
    van Ree RM; Gross S; Zelle DM; van der Heide JJ; Schouten JP; van Son WJ; Gans RO; Bakker SJ
    Transplantation; 2010 May; 89(10):1247-54. PubMed ID: 20559032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients.
    Sadeghi M; Daniel V; Naujokat C; Schmidt J; Mehrabi A; Zeier M; Opelz G
    Clin Transplant; 2010; 24(3):415-23. PubMed ID: 19925477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
    Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.